Copyright Reports & Markets. All rights reserved.

Global Gadoterate Meglumine Market Research Report 2021

Request for Sample of this report
Buy now

1 Gadoterate Meglumine Market Overview

  • 1.1 Product Overview and Scope of Gadoterate Meglumine
  • 1.2 Gadoterate Meglumine Segment by Type
    • 1.2.1 Global Gadoterate Meglumine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 1.8845Gm/5Ml
    • 1.2.3 3.769Gm/10Ml
    • 1.2.4 5.6535Gm/15Ml
    • 1.2.5 Others
  • 1.3 Gadoterate Meglumine Segment by Application
    • 1.3.1 Global Gadoterate Meglumine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Global Gadoterate Meglumine Market Size Estimates and Forecasts
    • 1.4.1 Global Gadoterate Meglumine Revenue 2016-2027
    • 1.4.2 Global Gadoterate Meglumine Sales 2016-2027
    • 1.4.3 Gadoterate Meglumine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gadoterate Meglumine Market Competition by Manufacturers

  • 2.1 Global Gadoterate Meglumine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Gadoterate Meglumine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Gadoterate Meglumine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Gadoterate Meglumine Manufacturing Sites, Area Served, Product Type
  • 2.5 Gadoterate Meglumine Market Competitive Situation and Trends
    • 2.5.1 Gadoterate Meglumine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Gadoterate Meglumine Players Market Share by Revenue
    • 2.5.3 Global Gadoterate Meglumine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gadoterate Meglumine Retrospective Market Scenario by Region

  • 3.1 Global Gadoterate Meglumine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Gadoterate Meglumine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Gadoterate Meglumine Market Facts & Figures by Country
    • 3.3.1 North America Gadoterate Meglumine Sales by Country
    • 3.3.2 North America Gadoterate Meglumine Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Gadoterate Meglumine Market Facts & Figures by Country
    • 3.4.1 Europe Gadoterate Meglumine Sales by Country
    • 3.4.2 Europe Gadoterate Meglumine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Gadoterate Meglumine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Gadoterate Meglumine Sales by Region
    • 3.5.2 Asia Pacific Gadoterate Meglumine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 China Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Gadoterate Meglumine Market Facts & Figures by Country
    • 3.6.1 Latin America Gadoterate Meglumine Sales by Country
    • 3.6.2 Latin America Gadoterate Meglumine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Gadoterate Meglumine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Gadoterate Meglumine Sales by Country
    • 3.7.2 Middle East and Africa Gadoterate Meglumine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Gadoterate Meglumine Historic Market Analysis by Type

  • 4.1 Global Gadoterate Meglumine Sales Market Share by Type (2016-2021)
  • 4.2 Global Gadoterate Meglumine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Gadoterate Meglumine Price by Type (2016-2021)

5 Global Gadoterate Meglumine Historic Market Analysis by Application

  • 5.1 Global Gadoterate Meglumine Sales Market Share by Application (2016-2021)
  • 5.2 Global Gadoterate Meglumine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Gadoterate Meglumine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Guerbet Group
    • 6.1.1 Guerbet Group Corporation Information
    • 6.1.2 Guerbet Group Description and Business Overview
    • 6.1.3 Guerbet Group Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Guerbet Group Gadoterate Meglumine Product Portfolio
    • 6.1.5 Guerbet Group Recent Developments/Updates
  • 6.2 GE
    • 6.2.1 GE Corporation Information
    • 6.2.2 GE Description and Business Overview
    • 6.2.3 GE Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 GE Gadoterate Meglumine Product Portfolio
    • 6.2.5 GE Recent Developments/Updates
  • 6.3 Bayer
    • 6.3.1 Bayer Corporation Information
    • 6.3.2 Bayer Description and Business Overview
    • 6.3.3 Bayer Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Bayer Gadoterate Meglumine Product Portfolio
    • 6.3.5 Bayer Recent Developments/Updates
  • 6.4 Sanochemia
    • 6.4.1 Sanochemia Corporation Information
    • 6.4.2 Sanochemia Description and Business Overview
    • 6.4.3 Sanochemia Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Sanochemia Gadoterate Meglumine Product Portfolio
    • 6.4.5 Sanochemia Recent Developments/Updates
  • 6.5 T2Pharma
    • 6.5.1 T2Pharma Corporation Information
    • 6.5.2 T2Pharma Description and Business Overview
    • 6.5.3 T2Pharma Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 T2Pharma Gadoterate Meglumine Product Portfolio
    • 6.5.5 T2Pharma Recent Developments/Updates
  • 6.6 b.e.imaging GmbH
    • 6.6.1 b.e.imaging GmbH Corporation Information
    • 6.6.2 b.e.imaging GmbH Description and Business Overview
    • 6.6.3 b.e.imaging GmbH Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 b.e.imaging GmbH Gadoterate Meglumine Product Portfolio
    • 6.6.5 b.e.imaging GmbH Recent Developments/Updates
  • 6.7 Hengrui Medicine
    • 6.6.1 Hengrui Medicine Corporation Information
    • 6.6.2 Hengrui Medicine Description and Business Overview
    • 6.6.3 Hengrui Medicine Gadoterate Meglumine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hengrui Medicine Gadoterate Meglumine Product Portfolio
    • 6.7.5 Hengrui Medicine Recent Developments/Updates

7 Gadoterate Meglumine Manufacturing Cost Analysis

  • 7.1 Gadoterate Meglumine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Gadoterate Meglumine
  • 7.4 Gadoterate Meglumine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Gadoterate Meglumine Distributors List
  • 8.3 Gadoterate Meglumine Customers

9 Gadoterate Meglumine Market Dynamics

  • 9.1 Gadoterate Meglumine Industry Trends
  • 9.2 Gadoterate Meglumine Growth Drivers
  • 9.3 Gadoterate Meglumine Market Challenges
  • 9.4 Gadoterate Meglumine Market Restraints

10 Global Market Forecast

  • 10.1 Gadoterate Meglumine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Gadoterate Meglumine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Gadoterate Meglumine by Type (2022-2027)
  • 10.2 Gadoterate Meglumine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Gadoterate Meglumine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Gadoterate Meglumine by Application (2022-2027)
  • 10.3 Gadoterate Meglumine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Gadoterate Meglumine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Gadoterate Meglumine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    1.8845Gm/5Ml
    3.769Gm/10Ml
    5.6535Gm/15Ml
    Others

    Segment by Application
    Hospitals
    Clinics

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Guerbet Group
    GE
    Bayer
    Sanochemia
    T2Pharma
    b.e.imaging GmbH
    Hengrui Medicine

    Buy now